PRKN and bladder transitional cell carcinoma: Subsequently, PGK1 interacts with and phosphorylates VDAC1, thereby enhancing the stability of the mitochondrial structure, and combating Pink1/Parkin/VDAC1‐mediated mitophagy, which leads to cisplatin resistance in BLCA.